Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Daniel E Salazar"'
Publikováno v:
Salazar, D E, Santos, L G, Wenzl, P & Hay, F 2020, ' Effect of dry heat on seed germination of Desmodium and Stylosanthes species ', Seed Science and Technology, vol. 48, no. 3, pp. 419-437 . https://doi.org/10.15258/sst.2020.48.3.11
Mechanical scarification with a scalpel is the best treatment to break physical dormancy and reach high germination percentages in many legumes. However, it is highly time-consuming. Given the ecological relationship between the presence of physical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95fb55b88fa4b6c1b4be66c6ca20a3ab
https://doi.org/10.15258/sst.2020.48.3.11
https://doi.org/10.15258/sst.2020.48.3.11
Autor:
Jeffrey S. Heier, Philip J. Rosenfeld, Jennifer Cerami, Carl C. Awh, Kate Fisher, Denis O'Shaughnessy, Michael N. Cohen, Daniel E Salazar
Publikováno v:
British Journal of Ophthalmology. 105:716-722
PurposeThe safety and efficacy of X-82, an orally administered inhibitor of vascular endothelial growth factor (VEGF) and platelet-derived growth factor, was investigated for treatment of wet age-related macular degeneration (AMD) in a phase II clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7674f9ef3ceba8b491d295fce86e7f
https://doi.org/10.1136/bjophthalmol-2020-316511
https://doi.org/10.1136/bjophthalmol-2020-316511
Autor:
Glenn Gormley, Daniel E. Salazar
Drug discovery and development are among the most important translational science activities that contribute to human health and well-being. This chapter presents an overview of the drug discovery and development process from the laboratory bench thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a2545734823c51b6eecb05826b1d1f
https://doi.org/10.1016/b978-0-12-802101-9.00041-7
https://doi.org/10.1016/b978-0-12-802101-9.00041-7
Autor:
Salim Abdool Karim, Donna K. Arnett, James R. Baker, Seema Basu, Stacey Berg, Gordon R. Bernard, Italo Biaggioni, Lisa Bomgaars, Robert A. Branch, Nancy J. Brown, Robert M. Califf, Henry C. Chueh, Steven A. Claas, William F. Crowley, Joann Data, George D. Demetri, Zeruesenay Desta, Ruth M. Dunne, Luigi Ferrucci, David A. Flockhart, Audrey Gassman, Rashmi Gopal-Srivastava, Glenn Gormley, Steven Grinspoon, Stephen C. Groft, Katherine E. Hartmann, Elizabeth Heitman, Christopher D. Herrick, Hylton V. Joffe, Kush Kapur, Mark D. Kellogg, Richard B. Kim, Bruce R. Korf, Greg Koski, Ronald L. Krall, Jessica Lasky-Su, Shawn N. Murphy, Christine Nguyen, Ailbhe C. O'Neill, Daniel J. Pallin, James Quinn, Keren Regev, Uwe E. Reinhardt, Todd W. Rice, Rose Marie Robertson, David Robertson, Dan M. Roden, Angela J. Rogers, Daniel E. Salazar, J. Sanford Schwartz, Alan F. Schatzberg, Ellen W. Seely, Joe V. Selby, César Serrano, Donald C. Simonson, Ann R. Stark, Stephanie Studenski, Clare M. Tempany, Marcia A. Testa, Thommey P. Thomas, Rommel G. Tirona, Stephanie L. Tomasic, Suzie Upton, Sten H. Vermund, Brent B. Ward, Howard L. Weiner, Scott T. Weiss, Danielle M. Whicher, Gordon H. Williams, Mary Woolley, Nathalie K. Zgheib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6be49395a04ee55ba637cd0f4cafb705
https://doi.org/10.1016/b978-0-12-802101-9.01002-4
https://doi.org/10.1016/b978-0-12-802101-9.01002-4
Publikováno v:
Systems Engineering. 17:157-165
A key mission for the Domestic Nuclear Detection Office DNDO is to build state and local capabilities through radiological and nuclear RN detection, support equipment, and training systems. To support DNDO's capabilities at local jurisdictional level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f8ce88800abebd1d89415427467dc8e
https://doi.org/10.1002/sys.21260
https://doi.org/10.1002/sys.21260
Autor:
Shashank Rohatagi, Helen Moore, Reinilde Heyrman, SaeHeum Song, Michelle Green, Raymond Miller, Timothy J. Carrothers, James Lee, Michael Melino, Daniel E. Salazar, Antonia Wang, Manini Patel
Publikováno v:
Clinical Pharmacology in Drug Development. 2:103-112
CS-8635, a fixed-dose triple combination of olmesartan, amlodipine, and hydrochlorothiazide, was developed to address the growing need for additional blood pressure (BP) reduction in patients not controlled with dual-combination therapies. Prior to P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b55fd7f812b63ff305ba02e447a5756
https://doi.org/10.1002/cpdd.17
https://doi.org/10.1002/cpdd.17
Autor:
Thomas G. Wells, Douglas L. Blowey, Reinilde Heyrman, Daniel E. Salazar, Janice E. Sullivan, Joseph R. Sherbotie, SaeHeum Song, Shashank Rohatagi, Jeffrey L. Blumer
Publikováno v:
Pediatric Drugs. 14:401-409
Background: The prevalence and importance of hypertension in younger patients is becoming increasingly recognized; however, only a limited number of clinical trials have been conducted in the pediatric population. Objective: The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db304e5a23e5af1e64ec3c7a7759b50
https://doi.org/10.2165/11631450-000000000-00000
https://doi.org/10.2165/11631450-000000000-00000
Autor:
Rebecca E. Wrishko, William L. Macias, C. Steven Ernest, Jeffrey S. Riesmeyer, Shashank Rohatagi, Daniel E. Salazar, David S. Small, Govinda Weerakkody, Junxiang Luo, Ying G. Li, Lan Ni
Publikováno v:
The Journal of Clinical Pharmacology. 52:789-797
In TRITON-TIMI 38, levels of the prasugrel active metabolite (pras-AM) were measured in a population pharmacokinetic substudy that characterized the intrinsic and extrinsic factors influencing exposure. Higher exposure to the pras-AM was observed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4723bcd9625f4d3ec49cb6079898eb6
https://doi.org/10.1177/0091270011406280
https://doi.org/10.1177/0091270011406280
Autor:
Robert P. Giugliano, Helen Kastrissios, Tomas S. Bocanegra, Simon Zhou, Michelle Green, Shashank Rohatagi, Indravadan Patel, Timothy J. Carrothers, Bruce E Dornseif, SaeHeum Song, Satoshi Kunitada, Minggao Shi, Jeanne Mendell, Daniel E. Salazar, Elliott M. Antman, Masaya Tachibana
Publikováno v:
Thrombosis and Haemostasis. 107:925-934
SummaryEdoxaban is a novel, orally available, highly specific direct inhibitor of factor Xa and is currently being developed for the treatment and prevention of venous thromboembolism and prevention of stroke and systemic embolism in patients with no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1257db9dae2118086028e4446bbb590
https://doi.org/10.1160/th11-08-0566
https://doi.org/10.1160/th11-08-0566
Autor:
D R Wada, Timothy J. Carrothers, Daniel E. Salazar, J Shi, Shashank Rohatagi, SaeHeum Song, Reinilde Heyrman
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:250-256
Modeling and simulation were used extensively in the development of an indication for the use of olmesartan medoxomil in pediatric patients with hypertension. Simulations based on models developed in adult patients indicated that two dose groups were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7c1aa45b4f0b3430391e237e569880
https://doi.org/10.1038/clpt.2011.220
https://doi.org/10.1038/clpt.2011.220